Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 4486 AL 4500

Dystonia: diagnosis and management

Albanese A, Di Giovanni M, Lalli S.

Eur J Neurol. 2019 Jan;26(1):5-17. doi: 10.1111/ene.13762. Epub 2018 Aug 18.

Tibialis anterior tendinopathy in a dystonic talipes calcaneovarus foot: A case treated by botulinum toxin

Sturbois-Nachef N, Kozlowski O, Benoit A, Fontaine C, Allart É.

Ann Phys Rehabil Med. 2019 Jan;62(1):60-63. doi: 10.1016/j.rehab.2018.06.007. Epub 2018 Jul 24.

Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity?

Deltombe T, Lejeune T, Gustin T.

Ann Phys Rehabil Med. 2019 Jul;62(4):220-224. doi: 10.1016/j.rehab.2018.07.008. Epub 2018 Aug 11.

A novel DDC gene deletion mutation in two Chinese mainland siblings with aromatic l-amino acid decarboxylase deficiency

Dai L, Ding C, Fang F.

Brain Dev. 2019 Feb;41(2):205-209. doi: 10.1016/j.braindev.2018.08.003. Epub 2018 Aug 23.

Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport(®) )

Simonetta-Moreau M, Picaut P, Volteau M, Poewe W.

Eur J Neurol. 2019 Jun;26(6):943-e65. doi: 10.1111/ene.13800. Epub 2018 Sep 30.

What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective

Thobois S, Prange S, Scheiber C, Broussolle E.

Parkinsonism Relat Disord. 2019 Feb;59:93-100. doi: 10.1016/j.parkreldis.2018.08.016. Epub 2018 Aug 30.

Motor and non-motor determinants of health-related quality of life in young dystonia patients

Eggink H, Coenen MA, de Jong R, Toonen RF, Eissens MH, Veenstra WS, Peall KJ, Sival DA, Elema A, Tijssen MA.

Parkinsonism Relat Disord. 2019 Jan;58:50-55. doi: 10.1016/j.parkreldis.2018.08.008. Epub 2018 Aug 29.

Effect of continuous intrathecal baclofen therapy in children: a systematic review

Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ.

Dev Med Child Neurol. 2019 Feb;61(2):128-134. doi: 10.1111/dmcn.14005. Epub 2018 Sep 6.

A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia

Macek TA, McCue M, Dong X, Hanson E, Goldsmith P, Affinito J, Mahableshwarkar AR.

Schizophr Res. 2019 Feb;204:289-294. doi: 10.1016/j.schres.2018.08.028. Epub 2018 Sep 3.

An inherited KMT2B duplication variant in a Chinese family with dystonia and/or development delay

Dai L, Ding C, Fang F.

Parkinsonism Relat Disord. 2019 Jun;63:227-228. doi: 10.1016/j.parkreldis.2018.08.021. Epub 2018 Aug 31.

Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia

Bladen JC, Feldman I, Favor M, Dizon M, Litwin A, Malhotra R.

Eye (Lond). 2019 Mar;33(3):349-352. doi: 10.1038/s41433-018-0203-3. Epub 2018 Sep 10.

Autosomal-recessive iron deficiency anemia, dystonia and hypermanganesemia caused by new variant mutation of the manganese transporter gene SLC39A14

Zeglam A, Abugrara A, Kabuka M.

Acta Neurol Belg. 2019 Sep;119(3):379-384. doi: 10.1007/s13760-018-1024-7. Epub 2018 Sep 19.

Biallelic TOR1A mutations cause severe arthrogryposis: A case requiring reverse phenotyping

Isik E, Aykut A, Atik T, Cogulu O, Ozkinay F.

Eur J Med Genet. 2019 Sep;62(9):103544. doi: 10.1016/j.ejmg.2018.09.011. Epub 2018 Sep 21.

An atypical case of early-onset dystonia with a novel missense variant in KMT2B

Zhou XY, Wu JJ, Sun YM.

Parkinsonism Relat Disord. 2019 Jun;63:224-226. doi: 10.1016/j.parkreldis.2018.09.020. Epub 2018 Sep 19.

Long-term outcomes of pallidal deep brain stimulation in X-linked dystonia parkinsonism (XDP): Up to 84 months follow-up and review of literature

Abejero JEE, Jamora RDG, Vesagas TS, Teleg RA, Rosales RL, Anlacan JP, Velasquez MS, Aguilar JA.

Parkinsonism Relat Disord. 2019 Mar;60:81-86. doi: 10.1016/j.parkreldis.2018.09.022. Epub 2018 Sep 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias